Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's morning trading, 87 companies set new 52-week lows.
AVITA Medical Sees Q2 Revenue $6.9M Vs $7M Est
Preliminary Results for the Quarter ended December 31 and Recent Updates:
Total revenue increased 35% to $6.9 million in the quarter ended December 31, 2021, compared to $5.1 million over
AVITA Medical Completes Enrollment In Pivotal Trial Evaluating The RECELL System For Soft-Tissue Reconstruction
AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)))), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet
Recap: AVITA Medical Q1 Earnings
AVITA Medical (NASDAQ:RCEL) reported its Q1 earnings results on Monday, November 8, 2021 at 04:00 PM.
Here's what investors need to know about the announcement.
Avita Therapeutics Q1 EPS $(0.24) Beats $(0.38) Estimate, Sales $7.00M Miss $7.10M Estimate
Avita Therapeutics (NASDAQ:RCEL) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.38) by 36.84 percent. This is a 50 percent increase over losses of $(0.48) per share from
Earnings Scheduled For November 8, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million.
AVITA Medical Announces Expanded Medicare Reimbursement To Outpatient Hospital And Ambulatory Surgical Centers
AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs,
Avita Therapeutics Q4 EPS $(0.19) Beats $(0.29) Estimate, Sales $10.30M Beat $7.88M Estimate
Avita Therapeutics (NASDAQ:RCEL) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.29) by 34.48 percent. The company reported quarterly sales of $10.30 million which beat